SUBSEQUENT EVENTS (Details) - USD ($)
|
|
|
|
|
|
3 Months Ended |
12 Months Ended |
|
Jul. 01, 2023 |
Mar. 26, 2022 |
Feb. 28, 2022 |
Jan. 03, 2022 |
Jul. 23, 2021 |
Mar. 31, 2022 |
Mar. 31, 2021 |
Dec. 31, 2022 |
Dec. 31, 2021 |
Dec. 31, 2020 |
Jan. 20, 2022 |
| Comstock Mining LLC | Scenario, Forecast |
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Membership interest, consideration purchased |
|
|
|
|
|
|
|
$ 7,750,000
|
|
|
|
| Sierra Springs Opportunity Fund, Inc. |
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Payments for advance to affiliate |
|
|
|
$ 1,300,000
|
|
$ 1,300,000
|
$ 2,150,000
|
|
$ 3,285,000
|
$ 1,650,000
|
|
| LP Biosciences LLC | Variable Interest Entity, Not Primary Beneficiary |
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Legal expense incurred |
|
|
|
|
$ 1,500,000
|
|
|
|
|
|
|
| Ownership percentage |
|
|
|
|
50.00%
|
|
|
|
|
|
|
| LP Biosciences LLC | Variable Interest Entity, Not Primary Beneficiary | Restricted Stock |
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Shares issued in connection with investment and financing commitments (shares) |
|
|
3,500,000
|
|
|
|
|
|
|
|
|
| Tonogold |
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Ownership percentage |
|
100.00%
|
|
|
|
|
|
|
|
|
|
| Tonogold note receivable, face value |
|
$ 6,650,000
|
|
|
|
|
|
|
|
|
|
| Tonogold | Scenario, Forecast |
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Non refundable option fee |
|
|
|
|
|
|
|
$ 750,000
|
|
|
|
| Additional non refundable extensible fee |
$ 500,000
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event |
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Cash award |
|
|
|
|
|
|
|
|
|
|
$ 150,000
|
| Subsequent Event | Sierra Springs Opportunity Fund, Inc. |
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Payments for advance to affiliate |
|
|
|
$ 1,300,000
|
|
|
|
|
|
|
|
| Subsequent Event | LP Biosciences LLC | Variable Interest Entity, Not Primary Beneficiary |
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Legal expense incurred |
|
|
$ 250,000
|
|
|
|
|
|
|
|
|
| Subsequent Event | LP Biosciences LLC | Variable Interest Entity, Not Primary Beneficiary | Restricted Stock |
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Shares issued in connection with investment and financing commitments (shares) |
|
|
3,500,000
|
|
|
|
|
|
|
|
|
| Subsequent Event | Tonogold |
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Ownership percentage |
|
100.00%
|
|
|
|
|
|
|
|
|
|
| Tonogold note receivable, face value |
|
$ 6,650,000
|
|
|
|
|
|
|
|
|
|